BioSpace News Archive

HKTDC Hong Kong International Medical and Healthcare Fair opens next Tuesday

An ageing global population and a general increase in health awareness are boosting demand for medical and healthcare equipment.

May 9, 2019
·
6 min read
Business

Takeda Divests Eye Drug to Novartis for $5.3 Billion

The sale of Xiidra to Novartis and TachoSil to Ethicon is part of Takeda’s strategy to pare down debt from its $62 billion acquisition of Shire.

May 9, 2019
·
3 min read
·
Alex Keown
Business

Ultra-Rare to Rare: Two Execs Talk About Alexion’s Shift

John Orloff and Brian Goff spoke with BioSpace about Alexion and new trends and developments the company is reporting.

May 9, 2019
·
6 min read
·
Mark Terry
Job Trends

Biotech Companies Provide High Median Salaries, Analysis Shows

For young people looking to find a career path, the pharmaceutical industry is a good one to go into, especially if salary is a major concern.

May 9, 2019
·
2 min read
·
Alex Keown
Drug Development

Research Roundup: Cancer Metastasis, Marathon Training, Fibromyalgia and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

May 9, 2019
·
6 min read
·
Mark Terry
Job Trends

Exclusive: Servier Establishes First U.S. Toehold in Boston with Immediate Focus on Oncology

The new company celebrated the grand opening of its 100-employee Boston facility that will initially focus its efforts on developing oncology therapies.

May 9, 2019
·
3 min read
·
Alex Keown
Business

Eisai and UK Dementia Research Institute Jointly Launch New Post-Doctoral Programme to Accelerate Dementia Research

Eisai Co., Ltd. and the UK Dementia Research Institute announced the launch of a joint post-doctoral programme to support the advancement of novel dementia research.

May 9, 2019
·
4 min read
Business

TLC Reports First Quarter of 2019 Financial Results and Provides Business Update

TLC announced financial results for the first quarter ended March 31, 2019, and provided a business update.

May 9, 2019
·
7 min read
FDA

Neuronascent Announces FDA Clearance of IND Application for NNI-362 an Aging Therapy to Treat Alzheimer’s Disease

Neuronascent Inc. announced that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug application for its proprietary oral therapeutic, NNI-362, to proceed into Phase 1 clinical testing in a healthy aged population.

May 9, 2019
·
6 min read
Business

Trialcare President & CEO Hans Christian Hoeck Joins SCRS Leadership Council

The Society for Clinical Research Sites announced that Hans Christian Hoeck, president and CEO of Trialcare Research, has joined the organization’s Leadership Council.

May 9, 2019
·
1 min read